Filing Details

Accession Number:
0001140361-14-037757
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-09 12:46:02
Reporting Period:
2014-10-08
Filing Date:
2014-10-09
Accepted Time:
2014-10-09 11:46:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1323974 Mwi Veterinary Supply Inc. MWIV Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) 020620757
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1334044 Jr N Robert Rebholtz 3041 W. Pasadena Dr.
Boise ID 83705
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Disposition 2014-10-08 1,718 $141.85 44,690 No 4 S Indirect See footnote
Common Stock, Par Value $0.01 Per Share Disposition 2014-10-08 2,407 $142.68 42,283 No 4 S Indirect See footnote
Common Stock, Par Value $0.01 Per Share Disposition 2014-10-08 200 $143.77 42,083 No 4 S Indirect See footnote
Common Stock, Par Value $0.01 Per Share Disposition 2014-10-08 1,557 $145.10 40,526 No 4 S Indirect See footnote
Common Stock, Par Value $0.01 Per Share Disposition 2014-10-08 526 $146.14 40,000 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share 34,266 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Rebholtz Descendants Trust on September 3, 2014.
  2. The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.43 to $141.42, inclusive. Mr. Rebholtz has provided to MWI Veterinary Supply, Inc. (the "Company") and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.44 to $143.06, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.77 to $143.78, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.79 to $145.41, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.99 to $146.19, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  7. Held by The Rebholtz Descendants Trust for the benefit of Mr. Rebholtz's family and certain other persons. Mr. Rebholtz expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.